These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 6233454
1. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion. Fantone JC, Kunkel RG, Kinnes DA. Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454 [Abstract] [Full Text] [Related]
2. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs. Heffner JE, Baron DA. J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556 [Abstract] [Full Text] [Related]
6. Morphine modulates inducible nitric oxide synthase expression and reduces pulmonary oedema induced by alpha-naphthylthiourea. Comert M, Sipahi EY, Ustun H, Isikdemir F, Numanoglu G, Barut F, Altunkaya H, Ozer Y, Niyazi Ayoglu F, Sipahi TH, Tekin IO, Banoglu ZN. Eur J Pharmacol; 2005 Mar 28; 511(2-3):183-9. PubMed ID: 15792787 [Abstract] [Full Text] [Related]
7. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. Fantone JC, Marasco WA, Elgas LJ, Ward PA. J Immunol; 1983 Apr 28; 130(4):1495-7. PubMed ID: 6300229 [Abstract] [Full Text] [Related]
9. Effect of the endothelin receptor antagonist tezosentan on alpha-naphthylthiourea-induced lung injury in rats. Atalay F, Yurdakan G, Yilmaz-Sipahi E. Kaohsiung J Med Sci; 2012 Feb 28; 28(2):72-8. PubMed ID: 22313533 [Abstract] [Full Text] [Related]
12. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. Chirkov YY, Chirkova LP, Sage RE, Horowitz JD. J Cardiovasc Pharmacol; 1995 Jun 28; 25(6):961-6. PubMed ID: 7564342 [Abstract] [Full Text] [Related]
13. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function. Saladino CF, Kosacolsky-Singer C, Fox R, Nethala V, Feffer SE, Jonas EA. Artery; 1993 Jun 28; 20(6):303-13. PubMed ID: 8010886 [Abstract] [Full Text] [Related]
14. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1. Qayumi AK, English JE, Duncan S, Ansley DM, Pearson B, Nikbakht-Sangari M, Sammartino C, Fradet G. J Heart Lung Transplant; 1997 Sep 28; 16(9):946-55. PubMed ID: 9322146 [Abstract] [Full Text] [Related]
15. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU). Boyd MR, Neal RA. Drug Metab Dispos; 1976 Sep 28; 4(4):314-22. PubMed ID: 8285 [Abstract] [Full Text] [Related]
18. Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats. Kort WJ, Bonta IL, Adolfs MJ, Westbroek DL. Prostaglandins Leukot Med; 1982 Jun 28; 8(6):661-4. PubMed ID: 7051048 [Abstract] [Full Text] [Related]
19. Suppression of acute inflammation by 15 methyl prostaglandin E1. Tate GA, Mandell BF, Schumacher HR, Zurier RB. Lab Invest; 1988 Aug 28; 59(2):192-9. PubMed ID: 2841538 [Abstract] [Full Text] [Related]
20. Acute effects of pentobarbital, thiopental and urethane on lung oedema induced by alpha-naphthythiourea (ANTU). Sipahi E, Ustün H, Niyazi Ayoglu F. Pharmacol Res; 2002 Mar 28; 45(3):235-9. PubMed ID: 11884221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]